|
Post by mango on May 27, 2018 7:28:26 GMT -5
Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes MellitusResults in eight patients suggest that once an optimal dose of TI is determined, type 2 diabetes patients can ingest meals with a wide range of CHO content or even skip meals without severe hypoglycemia. During this pilot study TI therapy improved A1C by - 1.63% (P = 0.00091) during 19 weeks of treatment. pdfs.semanticscholar.org/e174/2a16529012fb00174330ed4b0c8e930b384f.pdf
|
|